Gle1 — Gle1 Rna Export Mediator is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
| GLE1 RNA Export Mediator | |
|---|---|
| Gene Symbol | GLE1 |
| Full Name | GLE1 RNA export mediator |
| Chromosome | 9q34.3 |
| NCBI Gene ID | 2733 |
| OMIM | 603371 |
| Ensembl ID | ENSG00000108654 |
| UniProt ID | Q9BSC7 |
| Associated Diseases | Amyotrophic Lateral Sclerosis, Lethal Congenital Contracture Syndrome |
GLE1 (GLE1 RNA export mediator, also known as GLE1L) encodes an essential nuclear pore complex (NPC) protein critical for mRNA export from the nucleus to the cytoplasm. The protein is particularly important in neurons where local mRNA translation at synapses is crucial for synaptic plasticity, axonal regeneration, and neuronal survival. GLE1 dysfunction has been directly linked to amyotrophic lateral sclerosis (ALS) and lethal congenital contracture syndrome (LCCS1), highlighting its essential role in motor neuron biology.
GLE1 performs several critical cellular functions that are especially important in neurons:
GLE1 is a core component of the nuclear pore complex's cytoplasmic filaments. It interacts with the NUP214/CML1 export complex and facilitates the CRM1-mediated export of mRNAs through the nuclear pore channel. GLE1's role in mRNA export is essential for:
GLE1 localizes to stress granules (SGs), cytoplasmic membrane-less organelles that form in response to cellular stress. In neurons, stress granules are particularly important for:
GLE1 interacts with the eukaryotic translation initiation factor eIF3 complex, linking nuclear pore function to cytoplasmic translation machinery. This function is crucial for:
GLE1 is broadly expressed throughout the central nervous system with particularly high expression in:
Brain expression data from the Allen Human Brain Atlas shows elevated GLE1 mRNA in regions affected in ALS, including motor cortex and spinal cord.
| Disease | Variants | Inheritance | Mechanism |
|---|---|---|---|
| Amyotrophic Lateral Sclerosis | F483L, G617S, R495Q, L89V, D262V | Autosomal dominant | Disrupted mRNA export, impaired stress granule dynamics, TDP-43 mislocalization |
| Lethal Congenital Contracture Syndrome 1 | Q26X, R106X, W516X, Y702X | Autosomal recessive | Complete loss of GLE1 function, severe motor neuron dysfunction |
GLE1 mutations cause ALS through multiple interconnected mechanisms:
mRNA Export Defects: Impaired export of neuronal mRNAs leads to:
Stress Granule Abnormalities:
Nuclear Pore Complex Disruption:
| Strategy | Approach | Status |
|---|---|---|
| Gene therapy | AAV-mediated wild-type GLE1 delivery | Preclinical |
| Small molecules | GLE1 function modulators | Discovery |
| ASO therapy | Allele-specific silencing | Preclinical |
| Stress granule modulators | Target SG dynamics | Discovery |
The study of Gle1 — Gle1 Rna Export Mediator has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Kaneb HM, et al. GLE1 mutations in ALS. Nature Genetics 2012;44:611-616.
[2] Elman JS, et al. GLE1 regulates mRNA export in neurons. Journal of Neuroscience 2015;35:16567-16580.
[3] Boon J, et al. GLE1 and stress granules in ALS. Cell Reports 2017;21:2336-2348.
[4] Frankel WB, et al. GLE1 dosage and ALS pathogenesis. Acta Neuropathologica 2019;138:145-160.
[5] Kim HJ, et al. Nuclear pore dysfunction in ALS/FTD. Nature 2020;580:550-555.